| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |